NHC Reports 16.1% Rise in Revenues

By Chris Stiles • Friday, February 27 11:52 • Permanent Link

National Healthcare Corporation (NHC) reported its 2025 year-end earnings, showing a significant increase in net operating revenues and grant income. The company's net operating revenues and grant income for the year ended December 31, 2025, totaled $1,517,781,000, compared to $1,307,382,000 for the year ended December 31, 2024, representing a notable increase of 16.1%. This increase was driven by an 8.4% rise in same-facility net operating revenues and the acquisition of White Oak Manor, which contributed to the growth.

In terms of net income, the reported GAAP net income attributable to NHC for the year ended December 31, 2025, was $120,015,000, compared to $101,927,000 for the 2024 year. Excluding unrealized gains in the marketable equity securities portfolio and other non-GAAP adjustments, the adjusted net income for 2025 was $104,067,000, marking a substantial increase of 35.4% from the previous year.

The company's GAAP diluted earnings per share also saw an uptick, reaching $7.67 for the year ended December 31, 2025, compared to $6.53 for the previous year. Adjusted diluted earnings per share followed a similar trajectory, amounting to $6.65 for 2025, compared to $4.93 for 2024.

Looking at the quarterly performance, the reported GAAP net income attributable to NHC for the quarter ended December 31, 2025, significantly surpassed the figures from the same period in 2024, reaching $24,849,000 compared to $6,081,000. After excluding non-GAAP adjustments, the adjusted net income for the same period in 2025 was $28,774,000, representing a 10.9% increase from the previous year.

The GAAP diluted earnings per share for the quarter ended December 31, 2025, were $1.58, showing a substantial increase from $0.39 for the same period in 2024. Similarly, the adjusted diluted earnings per share for the fourth quarter of 2025 amounted to $1.83, compared to $1.66 for the corresponding period in 2024.

These figures indicate a strong financial performance for NHC in 2025, reflecting growth in both annual and quarterly net operating revenues, as well as notable increases in net income and earnings per share. Following these announcements, the company's shares moved -1.34%, and are now trading at a price of $137.15. For the full picture, make sure to review NATIONAL HEALTHCARE CORP's 8-K report.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.